Mesenchymal stem cell
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Mesenchymal stem cells or MSCs are multipotent stem cells that can differentiate into a variety of cell types. Cell types that MSCs have been shown to differentiate into in vitro or in vivo include osteoblasts, chondrocytes, myocytes, adipocytes, and as described lately, into beta-pancreatic islets cells. They can also transdifferentiate into neuronal cells.
While the terms Mesenchymal Stem Cell and Marrow Stromal Cell have been used interchangeably, neither term is sufficiently descriptive as discussed below:
- Mesenchyme is embryonic connective tissue that is derived from the mesoderm which differentiates into hematopoietic and connective tissue, whereas MSCs do not differentiate into hematopoietic cells.
- Stromal cells are connective tissue cells which form the supportive structure in which the functional cells of the tissue reside. While this is an accurate description for one function of MSCs, the term fails to convey the relatively recently discovered roles of MSCs in repair of tissue.
- Because the cells called MSCs by many labs today can encompass multipotent cells derived from other non-marrow tissues, such as adult muscle side-population cells or the Wharton's jelly present in the umbilical cord as well as in the dental pulp of deciduous baby teeth, yet do not have the capacity to reconstitute an entire organ, the term Multipotent Stromal Cell has been proposed as a better replacement.
Historical background
Scientists Ernest A. McCulloch and James E. Till first revealed the clonal nature of marrow cells in the 1960s.[1][1] An ex vivo assay for examining the clonogenic potential of multipotent marrow cells was later reported in the 1970s by Friedenstein and colleagues.[1][1] In this assay system, stromal cells were referred to as colony-forming unit-fibroblasts (CFU-f).
Subsequent experimentation revealed the plasticity of marrow cells and how their fate could be determined by environmental cues. Culturing marrow stromal cells in the presence of osteogenic stimuli such as ascorbic acid, inorganic phosphate and dexamethasone could promote their differentiation of into osteoblasts. In contrast, the addition of transforming growth factor-beta (TGF-b) could induce chondrogenic markers.
Modern culturing of MSCs
The majority of modern culture techniques still take a CFU-f approach, where raw unpurified bone marrow or ficoll-purified bone marrow monocytes are plated directly into cell culture plates or flasks. Mesenchymal stem cells, but not red blood cells nor haematopoetic progenitors are adherent to tissue culture plastic with 24-48 hours. However, at least one publication has identified a population of non-adherent MSCs that are not obtained by the direct plating technique.[1]
Other flow cytometry-based methods allow the sorting of bone marrow cells for specific surface markers, such as STRO-1.[1] STRO-1+ cells are generally more homogenous, have higher rates of adherence, and higher rates of proliferation, but the exact differences between STRO-1+ cells and MSCs aren't clear.[1]
Features of MSCs
MSCs have a large capacity for self-renewal while maintaining their multipotency. Beyond that, there is little that can be definitively said. The standard test to confirm multipotency is differentiation of the cells into osteoblasts, adipocytes, and chondrocytes, however, the degree to which the culture will differentiate varies among individuals and it isn't clear if this variation is due to a different amount of "true" progenitor cells in the culture or if individuals' progenitors have variable differentiation capacities. The capacity of cells to proliferate and differentiate is known to decrease with the age of the donor, as well as the time in culture. Likewise, whether this is due to a decrease in the number of MSCs, or a change to the existing MSCs isn't known. Some have reported that MSCs have an immunosuppressive effect, whereas others have found that MSCs effectively stimulate an immune response to internalized medium components such as bovine serum albumin. This confusion is directly related to the fact that as yet there is no test one could theoretically perform on a single cell to determine if that cell is an MSC or not. There are surface antigens which can be used to isolate a population of cells which have similar self-renewal and differentiation capacities, yet MSCs, as a population, typically do not all express the proposed markers, and it isn't certain which ones must be expressed in order for that cell to be classified as an MSC. It may be that the therapeutic properties attributed to MSCs results from the interaction between the different cells which make up an MSC culture, suggesting that there is no one cell which has all the properties.
See also
References
ar:خلية جذعية متعلقة باللحمة المتوسطة
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
